Journal of Lipid Research, Vol 33, 1817-1822, Copyright © 1992 by Lipid Research, Inc.

ARTICLES

Increased concentration of plasma cholesteryl ester transfer protein in nephrotic syndrome: role in dyslipidemia

P Moulin, GB Appel, HN Ginsberg and AR Tall
Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY 10032.

Hyperlipidemia is a prominent feature of the nephrotic syndrome. Lipoprotein abnormalities include increased very low and low density lipoprotein (VLDL and LDL) cholesterol and variable reductions in high density lipoprotein (HDL) cholesterol. We hypothesized that plasma cholesteryl ester transfer protein (CETP), which influences the distribution of cholesteryl esters among the lipoproteins, might contribute to lipoprotein abnormalities in nephrotic syndrome. Plasma CETP, apolipoprotein and lipoprotein concentrations were measured in 14 consecutive untreated and 7 treated nephrotic patients, 5 patients with primary hypertriglyceridemia, and 18 normolipidemic controls. Patients with nephrotic syndrome displayed increased plasma concentrations of apoB, VLDL, and LDL cholesterol. The VLDL was enriched with cholesteryl ester (CE), shown by a CE/triglyceride (TG) ratio approximately twice that in normolipidemic or hypertriglyceridemic controls (P < 0.001). Plasma CETP concentration was increased in patients with untreated nephrotic syndrome compared to controls (3.6 vs. 2.3 mg/l, P < 0.001), and was positively correlated with the CE concentration in VLDL (r = 0.69, P = 0.004) and with plasma apoB concentration (r = 0.68, P = 0.007). Treatment with corticosteroids resulted in normalization of plasma CETP and of the CE/TG ratio in VLDL. An inverse correlation between plasma CETP and HDL cholesterol was observed in hypertriglyceridemic nephrotic syndrome patients (r = -0.67, P = 0.03). The dyslipidemia of nephrotic syndrome includes increased levels of apoB-lipoproteins and VLDL that are unusually enriched in CE and likely to be atherogenic. Increased plasma CETP probably plays a significant role in the enrichment of VLDL with CE, and may also contribute to increased concentrations of apoB-lipoproteins and decreased HDL cholesterol in some patients.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. J. Barter and J. J.P. Kastelein Targeting Cholesteryl Ester Transfer Protein for the Prevention and Management of Cardiovascular Disease J. Am. Coll. Cardiol., February 7, 2006; 47(3): 492 - 499. [Abstract] [Full Text] [PDF]

				G. J. de Grooth, A. H. E. M. Klerkx, E. S. G. Stroes, A. F. H. Stalenhoef, J. J. P. Kastelein, and J. A. Kuivenhoven A review of CETP and its relation to atherosclerosis J. Lipid Res., November 1, 2004; 45(11): 1967 - 1974. [Abstract] [Full Text] [PDF]

				N.D. Vaziri and K.H. Liang Acyl-Coenzyme A:Cholesterol Acyltransferase Inhibition Ameliorates Proteinuria, Hyperlipidemia, Lecithin-Cholesterol Acyltransferase, SRB-1, and Low-Denisty Lipoprotein Receptor Deficiencies in Nephrotic Syndrome Circulation, July 27, 2004; 110(4): 419 - 425. [Abstract] [Full Text] [PDF]

				S. Jansen, J. Lopez-Miranda, P. Castro, F. Lopez-Segura, C. Marin, J. M Ordovas, E. Paz, J. Jimenez-Pereperez, F. Fuentes, and F. Perez-Jimenez Low-fat and high-monounsaturated fatty acid diets decrease plasma cholesterol ester transfer protein concentrations in young, healthy, normolipemic men Am. J. Clinical Nutrition, July 1, 2000; 72(1): 36 - 41. [Abstract] [Full Text] [PDF]

				K. M. Wasan, M. Ramaswamy, W. Wong, and P. H. Pritchard Lipid Transfer Protein I Facilitated Transfer of Cyclosporine from Low- to High-Density Lipoproteins is Only Partially Dependent on its Cholesteryl Ester Transfer Activity J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 599 - 605. [Abstract] [Full Text]

				S. Braschi, D. Masson, G. Rostoker, E. Florentin, A. Athias, C. Martin, B. Jacotot, P. Gambert, C. Lallemant, and L. Lagrost Role of Lipoprotein-Bound NEFAs in Enhancing the Specific Activity of Plasma CETP in the Nephrotic Syndrome Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2559 - 2567. [Abstract] [Full Text]

				F. Tato, G. L. Vega, and S. M. Grundy Determinants of Plasma HDL-Cholesterol in Hypertriglyceridemic Patients: Role of Cholesterol-Ester Transfer Protein and Lecithin Cholesteryl Acyl Transferase Arterioscler. Thromb. Vasc. Biol., January 1, 1997; 17(1): 56 - 63. [Abstract] [Full Text]

				B. Foger, A. Ritsch, A. Doblinger, H. Wessels, and J. R. Patsch Relationship of Plasma Cholesteryl Ester Transfer Protein to HDL Cholesterol: Studies in Normotriglyceridemia and Moderate Hypertriglyceridemia Arterioscler. Thromb. Vasc. Biol., December 1, 1996; 16(12): 1430 - 1436. [Abstract] [Full Text]

				S. Braschi, L. Lagrost, E. Florentin, C. Martin, A. Athias, P. Gambert, M. Krempf, C. Lallemant, and B. Jacotot Increased Cholesteryl Ester Transfer Activity in Plasma From Analbuminemic Patients Arterioscler. Thromb. Vasc. Biol., March 1, 1996; 16(3): 441 - 449. [Abstract] [Full Text]

				L. Lagrost, E. Florentin, V. Guyard-Dangremont, A. Athias, H. Gandjini, C. Lallemant, and P. Gambert Evidence for Nonesterified Fatty Acids as Modulators of Neutral Lipid Transfers in Normolipidemic Human Plasma Arterioscler. Thromb. Vasc. Biol., September 1, 1995; 15(9): 1388 - 1396. [Abstract] [Full Text]

				F. Tato, G. L. Vega, and S. M. Grundy Bimodal Distribution of Cholesteryl Ester Transfer Protein Activities in Normotriglyceridemic Men With Low HDL Cholesterol Concentrations Arterioscler. Thromb. Vasc. Biol., April 1, 1995; 15(4): 446 - 451. [Abstract] [Full Text]

				F. Tato, G. L. Vega, A. R. Tall, and S. M. Grundy Relation Between Cholesterol Ester Transfer Protein Activities and Lipoprotein Cholesterol in Patients With Hypercholesterolemia and Combined Hyperlipidemia Arterioscler. Thromb. Vasc. Biol., January 1, 1995; 15(1): 112 - 120. [Abstract] [Full Text]